The 50-hospital study, sponsored by the National Institutes of Health and known as TIMI II (for thrombolysis in myocardial infarction phase II trial), involved 3,262 patients who .
Pulmonary Embolism Trial Comparing Endovascular Ultrasound to Standard of Care Anticoagulation Published in the ... EKOS Corporation, a BTG International group company ), located in Bothell, Washington in the United States, today announced the publication of the results of its Ultrasound Accelerated Thrombolysis of Pulmonary Embolism trial in the peer-reviewed journal of the American Heart Association, CIRCULATION.
Jan. 20, 2014 - Business Wire via Yahoo! Finance